KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsCapital Expenditure By SegmentCost Of Goods And Services SoldDeferred IncomeDepreciation And Amortization By SegmentEmployee StatisticsGross Margin %Gross Margin By Segment %Gross Margin By Segment Annual %Gross ProfitGross Profit By SegmentGross Profit By Segment AnnualIncome Before Income TaxLong Lived Assets By GeographyNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Lease LiabilitiesOperating Margin By Segment %Operating Profit By SegmentOpex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment, Net BreakdownRevenue By Country AnnualRevenue By Country Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By Market GroupRevenue By Market Group %Revenue By Market Group AnnualRevenue By Market Group Annual %Revenue By Product CategoryRevenue By Product Category %Revenue By Product Category AnnualRevenue By Product Category Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Gross Profit (2016 - 2025)

Historic Gross Profit for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $303.9 million.

  • West Pharmaceutical Services' Gross Profit rose 1107.46% to $303.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 1056.58%. This contributed to the annual value of $1.1 billion for FY2025, which is 1056.58% up from last year.
  • According to the latest figures from Q4 2025, West Pharmaceutical Services' Gross Profit is $303.9 million, which was up 1107.46% from $294.3 million recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Gross Profit high stood at $321.5 million for Q2 2022, and its period low was $230.0 million during Q2 2024.
  • Moreover, its 5-year median value for Gross Profit was $276.0 million (2023), whereas its average is $277.2 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 6281.44% in 2021, then crashed by 2107.07% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Gross Profit (Quarter) stood at $300.6 million in 2021, then dropped by 12.81% to $262.1 million in 2022, then increased by 6.14% to $278.2 million in 2023, then dropped by 1.65% to $273.6 million in 2024, then increased by 11.07% to $303.9 million in 2025.
  • Its Gross Profit was $303.9 million in Q4 2025, compared to $294.3 million in Q3 2025 and $273.9 million in Q2 2025.